Durable lymph-node expansion is associated with the efficacy of therapeutic vaccination

Publication information:

Najibi A, Lane R, Sobral M, Bovone G, Kang S, Freedman B, Gutierrez Estupinan J, Elosegui-Artola A, Tringides C, Dellacherie M, et al. Durable lymph-node expansion is associated with the efficacy of therapeutic vaccination. Nat Biomed Eng. 2024. doi:10.1038/s41551-024-01209-3

Abstract

Following immunization, lymph nodes dynamically expand and contract. The mechanical and cellular changes enabling the early-stage expansion of lymph nodes have been characterized, yet the durability of such responses and their implications for adaptive immunity and vaccine efficacy are unknown. Here, by leveraging high-frequency ultrasound imaging of the lymph nodes of mice, we report more potent and persistent lymph-node expansion for animals immunized with a mesoporous silica vaccine incorporating a model antigen than for animals given bolus immunization or standard vaccine formulations such as alum, and that durable and robust lymph-node expansion was associated with vaccine efficacy and adaptive immunity for 100 days post-vaccination in a mouse model of melanoma. Immunization altered the mechanical and extracellular-matrix properties of the lymph nodes, drove antigen-dependent proliferation of immune and stromal cells, and altered the transcriptional features of dendritic cells and inflammatory monocytes. Strategies that robustly maintain lymph-node expansion may result in enhanced vaccination outcomes.